Bristol Operating Cycle from 2010 to 2026

BMY Stock  USD 55.86  0.04  0.07%   
Bristol Myers Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle is likely to outpace its year average in 2026. During the period from 2010 to 2026, Bristol Myers Operating Cycle regression line of annual values had r-squared of  0.06 and arithmetic mean of  187.04. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
176.78
Current Value
221.9
Quarterly Volatility
39.22062348
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.6 B, Interest Expense of 2.4 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.95, Dividend Yield of 0.0378 or PTB Ratio of 7.0. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Build AI portfolio with Bristol Stock
Check out the analysis of Bristol Myers Correlation against competitors.

Latest Bristol Myers' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Bristol Myers Squibb over the last few years. It is Bristol Myers' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Pretty Stable
   Operating Cycle   
       Timeline  

Bristol Operating Cycle Regression Statistics

Arithmetic Mean187.04
Geometric Mean183.33
Coefficient Of Variation20.97
Mean Deviation30.80
Median183.83
Standard Deviation39.22
Sample Variance1,538
Range156
R-Value(0.25)
Mean Square Error1,535
R-Squared0.06
Significance0.32
Slope(1.98)
Total Sum of Squares24,612

Bristol Operating Cycle History

2026 221.9
2025 176.78
2024 153.73
2023 173.24
2022 153.61
2021 137.45
2020 126.97

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 176.78  221.90 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.